Guy represents bio technology and healthcare clients on technology-driven transactions from early planning stages to ultimate integration. He counsels clients on obtaining and safeguarding IP rights from innovator employees through confidential invention disclosure and assignment agreements from strategic partners under licensing and option agreements, or through outright acquisitions. His IP practice spans innovations in biotechnology, pharmaceuticals, biologics, chemistry and plant sciences.
